{"id":"W3187545758","doi":"10.1136/bmjopen-2020-046588","title":"A phase 3 randomised study of enzalutamide plus leuprolide and enzalutamide monotherapy in high-risk non-metastatic hormone-sensitive prostate cancer with rising PSA after local therapy: EMBARK study design","year":2021,"lang":"en","type":"article","venue":"BMJ Open","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Astellas Pharma; Pfizer","keywords":"Enzalutamide; Medicine; Prostate cancer; Androgen deprivation therapy; Placebo; Internal medicine; Prostate-specific antigen; Oncology; Urology; Radiation therapy; Prostatectomy; Hormone therapy; Cancer; Breast cancer; Pathology; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001693486,0.0004140296,0.001356353,0.0002383057,0.000128527,0.0001326284,0.0001624009,0.00005007899,0.00004059874],"category_scores_gemma":[0.00006884027,0.0002769653,0.00006373306,0.0006426058,0.0001807502,0.0002703103,0.0001695578,0.0003613732,0.000002691071],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003435834,"about_ca_system_score_gemma":0.001429875,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008837108,"about_ca_topic_score_gemma":0.002993191,"domain_scores_codex":[0.9961908,0.001154007,0.0006937869,0.000781181,0.0006679954,0.0005122123],"domain_scores_gemma":[0.998279,0.0003394961,0.0002892702,0.0005771535,0.0003082233,0.0002068161],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7222354,0.01176542,0.09665717,0.0001483204,0.003404569,0.01041811,0.07066265,0.001723491,0.006313116,3.926174e-7,0.00005901858,0.0766123],"study_design_scores_gemma":[0.751318,0.02528452,0.1307437,0.0008464897,0.0008207485,0.00008866566,0.05184543,0.00423446,0.03415848,0.00005450121,0.00001125122,0.0005937659],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9574565,0.001785097,0.001087221,0.0001799917,0.00003203154,0.03934556,0.00005650984,0.00001727656,0.00003984046],"genre_scores_gemma":[0.9876737,0.001137613,0.001042331,0.0001655016,0.00003743783,0.009426699,0.0000163421,0.00008078932,0.0004195771],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07601853,"threshold_uncertainty_score":0.9999682,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05980164032402145,"score_gpt":0.4043480596106108,"score_spread":0.3445464192865894,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}